![]() |
市場調査レポート
商品コード
1549423
IoT医療機器の世界市場の評価:製品タイプ別、接続技術別、エンドユーザー別、地域別、機会、予測(2017年~2031年)IoT Medical Devices Market Assessment, By Product, By Type, By Connectivity Technology, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
||||||
カスタマイズ可能
|
IoT医療機器の世界市場の評価:製品タイプ別、接続技術別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年09月06日
発行: Market Xcel - Markets and Data
ページ情報: 英文 245 Pages
納期: 3~5営業日
|
世界のIoT医療機器の市場規模は、2023年の396億8,000万米ドルから2031年に1,385億7,000万米ドルに達すると予測され、予測期間の2024年~2031年にCAGRで16.92%の成長が見込まれます。この成長は、医療データの精度と信頼性を高めるセンサー技術の急速な進化など、複数の主な要因によって推進されています。5Gや改良型の無線ネットワークなどの接続性の進歩は、シームレスなデータ転送と機器間のリアルタイム通信を容易にします。さらに、先進のデータアナリティクスが患者情報の処理と活用を変革し、より個別化された効果的な治療につながります。
IoT医療機器は、医師が患者の心拍数や血糖値などの健康状態を継続的にモニターできるようにすることで、医療の改善に重要な役割を果たしています。センサーとデータアナリティクスの進歩により、診断の精度が高まり、健康問題が深刻化する前に予防することができます。これらは遠隔医療や遠隔モニタリングをサポートし、サービスが行き届いていない地域でのよりよい医療提供につながります。さらに、データ収集の自動化によって医療の提供が促進され、効率向上とコスト削減につながります。IoT機器はまた、展開されたセンサーからのリアルタイムアラートで即時の緊急対応を支援するため、患者の安全にも寄与します。
さらに、投資の増加や政府の積極的な取り組みが、世界のIoT医療機器市場の成長を後押ししています。例えば2024年4月、IIT Madrasは、UN SG3「健康と福祉」に向けインド初のモバイル医療機器校正施設を経営しました。これにより、救命医療機器の精度が向上し、IoTソリューションの重要性がさらに強く示されると予測されます。この動向は、よりよい患者ケアを可能にし、健康転帰を改善し、データ変更効率で医療コストを削減するこれらの融合ソリューションの勢いを高め、市場を急速に拡大させると見られます。
遠隔医療と遠隔患者モニタリングの採用拡大
遠隔医療と遠隔患者モニタリングの台頭は主に、IoT医療機器市場で見られるシームレスな進行と、政府による有利な義務付けによって後押しされています。先進の遺伝子検査や精巧な遠隔モニタリングサービスのような近年の進歩も、患者のケアと管理を向上させます。研究資金や支援規則などの政府プログラムは、これらの開発を促進する上で極めて重要です。さらに、疾患の予防や長期的な疾病管理が重視されるようになったことで、こうした技術に対する需要が高まっています。デジタルヘルスツールの使用に対する患者の意欲の高まりは、これらの技術の採用をさらに後押ししています。
例えば2024年1月、Rudolf Riester GmbHは、DocsinCloudsによる初の完全な遠隔医療ソリューションを提供します。この遠隔医療ソリューションは、多様な医療機器を統合するように設計されており、さまざまな臨床や遠隔医療のシナリオにおいて柔軟性と効率性を保証します。遠隔診察と患者モニタリングを可能にするこれらの方策は、地理的な障壁に関係なく、質の高いケアが患者に提供されていることを保証するものです。
慢性疾患の流行が市場成長を促進
慢性疾患の流行は、IoT医療機器市場の成長の主な促進要因となっています。IoTは、糖尿病、高血圧、心血管疾患などの疾患に対して、患者の状態を正確にモニタリングすることで、その扉に入る機会を提供します。生理学的モニタリングシステムは、継続的なリアルタイムのデータ収集と遠隔患者追跡を可能にし、合併症の早期発見、長期的なパラメーターの推移、よりタイムリーな治療介入を向上させ、治療関連の副作用が少なく、より望ましい転帰につながっています。例えば、世界保健機関(WHO)のChina Country Assessment Report on Aging and Healthによると、中国の60歳を超える高齢者で、高血圧、糖尿病、脳卒中、がん、高コレステロール血症などの慢性非伝染性疾患に罹患している人口は、少なくとも2030年まで平均40%以上増加すします。同レポートはさらに、老年人口の割合は2040年までに28%に増加すると予測しています。
当レポートでは、世界のIoT医療機器市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
The global IoT medical devices market is projected to witness a CAGR of 16.92% during the forecast period 2024-2031, growing from USD 39.68 billion in 2023 to USD 138.57 billion in 2031. This growth is propelled by several key factors, including the rapid evolution of sensor technology, which enhances the precision and reliability of medical data. Advances in connectivity, such as 5G and improved wireless networks, facilitate seamless data transfer and real-time communication between devices. Additionally, sophisticated data analytics transform patient information processing and utilization, leading to more personalized and effective care.
Internet of Things (IoT) medical devices play a key role in improving healthcare by allowing doctors to monitor patients' health continuously, like their heart rate and blood sugar levels This is crucial for managing chronic diseases, allowing for timely interventions and personalized treatment plans. With the advancements in sensors and data analytics, there is a higher precision of diagnosis as well as prevention against health issues before they escalate. These can support telemedicine and remote monitoring leading to better healthcare delivery in underserved areas. Moreover, it tends to boost healthcare delivery through data collection automation which pays off with higher efficiency and reduced cost. IoT devices also contribute to patient safety, as they aid in real-time alerts from deployed sensors for immediate emergency responses.
In addition, the increasing investments and favorable government initiatives are driving the growth of the global IoT medical devices market. For instance, In April 2024, IIT Madras ran India's first mobile medical devices calibration facility for UN SG3- health and well-being. This is expected to improve the accuracy of life-saving medical devices, further underscoring the importance of IoT solutions. This trend will increase traction and rapid market expansion for these converging solutions that enable better patient care, improve health outcomes, and reduce healthcare costs on data Change efficiencies.
Growing Adoption of Telemedicine and Remote Patient Monitoring
The rise of telemedicine and remote patient monitoring is primarily fueled by the seamless progress witnessed in an IoT medical devices market accompanied by favorable government mandates. Recent advancements, like advanced genetic testing and sophisticated remote monitoring services, also improve patient care and management. Government programs, such as research funding and supportive rules, are crucial in facilitating these developments. Additionally, the growing emphasis on preventing illness and managing long-term diseases has increased the demand for these technologies. This growing willingness of patients to use digital health tools further boosts the adoption of these technologies.
For instance, in January 2024, Rudolf Riester GmbH brings the first complete Telemedicine solution with DocsinClouds. The Telemedicine solution is designed to integrate a diverse range of medical devices, ensuring flexibility and efficiency in various clinical and remote care scenarios. These measures, which allow remote consultations and patient monitoring are an assurance that high-quality care is being given to patients irrespective of geographical barriers.
Increasing Prevalence of Chronic Diseases Drive Market Growth
Increasing incidence of chronic diseases acts as a major driver for the growth of IoT medical devices market. IoT provides an opportunity to enter the door for diseases such as diabetes, hypertension, and cardiovascular disease with accurate monitoring of patient condition). Physiologic monitoring systems allow continuous real-time data collection and remote patient tracking to improve early complication detection, long-term parameter trending, and more timely therapeutic intervention which has led to more desirable outcomes with less treatment-related side effects. For instance, as per World Health Organization's (WHO) China Country Assessment Report on Aging and Health, the population in China aged above 60 in China who have chronic non-communicable diseases, such as hypertension, diabetes, stroke cancer, or/ hypercholesterolemia will grow by a minimum average of 40% reaching at least up to year 2030. The report further stated that the proportion of the geriatric population is anticipated to increase to 28% by 2040.
Wearable Medical Devices Have a Pivotal Role in the Global IoT Market
The growth of wearable medical devices in the IoT medical device market is attributable to advancements in technology and increasing health awareness among consumers, along with growing prevalence & incidence rates for chronic diseases as well as rising market opportunities. Additionally, new technologies like AI & 5G being employed in wearables make the data transmitting and real-time health monitoring operation seamless at one end but on the other side is offering a proactive healthcare paradigm more often required for the present generation of young adults which is quite motivated to be healthy, thus fuelling a bullish run over adoption part.
For instance, in January 2024, Abbott introduced Lingo in the United Kingdom a novel wearable technology with app functionality that provides real-time glucose tracking. It gives users special advice and support to help them get healthier, sleep better, feel happier, stay focused, have more energy, and control their cravings more easily.
North America to Hold Major Share of Global IoT Medical Devices Market
North America dominates the global market for IoT medical devices as broad adoption of smartphones and mobile platforms among the North American population is likely to lead towards continued progress in wearable & remote patient monitoring services, and increased desire for its implementation of Electronic Health Records (EHRs). Government programs that foster digital health further support this area. The trend for increasing adoption of self-operated eHealth platforms due to the lesser doctor-to-patient ratio at various places provides an opportunity for market expansion. All these factors, including technology improvements, market needs, and supportive systems, make North America a major player in the global IoT medical devices landscape. In February 2024, KORE Wireless Group and Medical Guardian LLC announced that they had entered a partnership to bring an e-SIM-enabled medical alert device to market. This innovative solution addresses cell signal issues and healthcare access gaps by allowing electronic carrier switching for continuous 24/7 connectivity.
Future Market Scenario (2024-2031F)
The demand for IoT medical devices is anticipated to rise as healthcare systems increasingly rely on real-time monitoring and early detection of diseases to enhance patient care. These systems minimize human error and automate the process of capturing data, thereby providing more precise information in real-time. In addition, when this is enriched by greater data insights it significantly eases clinician decision-making. This transition allows better care coordination and early interventions, ultimately promoting improved health outcomes while at the same time making healthcare delivery a more efficient process. World Patient Safety Day is an example of this focus, working to enhance the safety and quality culture.
Key Players Landscape and Outlook
The global IoT medical devices market is competitive, with a major number of players at local levels. Regulatory approvals of company products, mergers and acquisitions, and collaborations are the most common market strategies that have been observed in recent times.
In January 2024, GE HealthCare Technologies Inc. announced its agreement to acquire MIM Software Inc., a prominent provider of medical imaging analysis and artificial intelligence (AI) solutions for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology. GE Healthcare Technologies Inc. plans to integrate MIM software's advanced imaging analytics and digital workflow capabilities to accelerate innovation and enhance its solutions across various care areas, ultimately benefiting patients and healthcare systems worldwide.
In May 2023, Medtronic plc, a global leader in healthcare technology, announced that it has entered into definitive agreements to acquire EOFlow Co. Ltd, the manufacturer of the EOPatch - a tubeless, wearable, and fully disposable insulin delivery device. By integrating EOFlow's technology with Medtronic's Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM), the company aims to enhance its ability to meet the diverse needs of individuals with diabetes, regardless of their treatment stage or insulin delivery preferences.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.